We sit down with England’s Chief Scientific Officer, Professor Dame Sue Hill, to learn how genomics will influence the future of pathology.

An iridium-based photodynamic drug accumulates in cancer cell nuclei – and destroys them from within.

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.

Differences in bacterial diversity in the gut could be used to identify patients with Barrett’s esophagus and esophageal cancer.

Tomorrow’s cures for retinopathies will likely include advanced gene and cell therapies delivered by precision surgery.

China drafts new gene-editing regulations – but concerns over their enforcement remain.

How iPSC-derived 3D organoids and high-throughput histology opens a new door to personalized medicine development and testing.

The latest advances in translational medicine – condensed into 20-second servings.

Three leading lights in the neuro-oncology sphere explain what inspired them, how the field has evolved, and what challenges lie ahead.

New evidence suggests there’s more to metastasis than MMPs, demanding a therapeutic rethink.